Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150048/S093

INSPIRIS RESILIA Aortic Valve; MITRIS RESILIA Mitral Valve

Edwards Lifesciences, LLC · Decision date Oct 16, 2025

FDA DECISIONP150048/S093

What did the FDA decide?

FDA records P150048/S093 as a supplement to PMA P150048, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 16, 2025.

FDA approval order statement

addition of final bioburden reduction and preliminary packaging processes to an existing cleanroom, and increased maximum capacity in the cleanroom
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P150048/S093
Regulatory pathway
PMA supplement
Product code
LWR
Decision code
OK30
Decision date
Oct 16, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: heart-valve, non-allograft tissue.

Product code
LWR
FDA device class
3

For the original device and its historical approval scope, see PMA P150048. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150048 · Original PMA

    EDWARDS PERICARDIAL AORTIC BIOPROSTHESIS (MODEL 11000A) and EDWARDS INSPIRIS RESILIA AORTIC VALVE (MODEL 11500)

  2. P150048/S093 received

    Application receipt date recorded by FDA.

  3. P150048/S093 · FDA decision

    30-Day Notice

  4. P150048/S092 · Related supplement

    TRIFORMIS RESILIA Tricuspid Valve

  5. P150048/S095 · Related supplement

    Edwards INSPIRIS RESILIA Aortic Valve, Model 11500A, Sizes 19mm, 21mm, 23mm, 25mm, 27mm, and 29mm; Edwards KONECT RESILI

  6. P150048/S096 · Related supplement

    TRIFORMIS RESILIA Tricuspid Valve, Model 11300T

  7. P150048/S097 · Related supplement

    TRIFORMIS RESILIA Tricuspid Valve, Model 11300T

  8. P150048/S098 · Related supplement

    INSPIRIS RESILIA Aortic Valve; KONECT RESILIA Aortic Valve Conduit (AVC); MITRIS RESILIA Mitral Valve

  9. P150048/S099 · Related supplement

    INSPIRIS RESILIA Aortic Valve, MITRIS RESILIA Mitral Valve, KONECT RESILIA Aortic Valved Conduit

  10. P150048/S094 · Related supplement

    TRIFORMIS RESILIA Tricuspid Valve, Model 11300T Available in sizes: 25, 27, 29, 31 and 33 mm

  11. P150048/S101 · Related supplement

    INSPIRIS RESILIA Aortic Valve

  12. P150048/S103 · Related supplement

    EINSPIRIS RESILIA Aortic Valve, Model 11500A; KONECT RESILIA Aortic Valved Conduit (AVC), Model 11060A

  13. P150048/S100 · Related supplement

    INSPIRIS RESILIA Aortic Valve; MITRIS RESILIA Mitral Valve

  14. P150048/S104 · Related supplement

    INSPIRIS RESILIA Aortic Valve (11500A), KONECT RESILIA Aortic Valve Conduit (AVC) (11060A), MITRIS RESILIA Mitral Valv

Timeline entries are records held by MedtechLedger for P150048. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150048

Product / regulatory recordCompanyPathwayDecision dateSource
Edwards Lifesciences, LLCPMA approvalJun 29, 2017FDA
Edwards Lifesciences, LLCPMA supplementOct 27, 2025FDA
Edwards Lifesciences, LLCPMA supplementDec 17, 2025FDA
Edwards Lifesciences, LLCPMA supplementFeb 6, 2026FDA
Edwards Lifesciences, LLCPMA supplementFeb 6, 2026FDA
Edwards Lifesciences, LLCPMA supplementMar 11, 2026FDA
Edwards Lifesciences, LLCPMA supplementApr 16, 2026FDA
Edwards Lifesciences, LLCPMA supplementMay 26, 2026FDA
Edwards Lifesciences, LLCPMA supplementJun 3, 2026FDA
Edwards Lifesciences, LLCPMA supplementJul 29, 2026FDA
Edwards Lifesciences, LLCPMA supplementOct 22, 2026FDA
Edwards Lifesciences, LLCPMA supplementOct 28, 2026FDA

Explore the linked device profile

Other records with product code LWR

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records